Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/16/21
End: 11/21/22
Due: 11/21/23
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 05/31/26
Due: 05/31/27
Phase: N/A
Priority: Normal
Start: 04/11/24
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 05/31/21
End: 05/31/22
Due: 05/31/23
Phase: N/A
Priority: Normal
Start: 06/30/17
End: 01/31/22
Due: 01/31/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| EmbracePlus SpO2 Accuracy Validation | NCT04964609 | Empatica, Inc. | user2@example.com | None | 2021-06-16 | 2022-11-21 | 2023-11-21 | - | - | 2025-07-14 |
| Embrace: Seizure Characterization | NCT03206502 | Empatica, Inc. | user2@example.com | None | 2016-05-31 | 2026-05-31 | 2027-05-31 | - | - | 2025-07-14 |
| Forecasting Seizures Using Intelligent Wearable Technology for Health Tracking | NCT06275685 | Empatica, Inc. | user2@example.com | None | 2024-04-11 | 2026-06-30 | 2027-06-30 | - | - | 2025-07-14 |
| EmbracePlus, Care App and Aura Usability Study | NCT04807608 | Empatica, Inc. | user2@example.com | None | 2021-05-31 | 2022-05-31 | 2023-05-31 | - | - | 2025-07-14 |
| Generalized Seizure Detection And Alerting In The EMU With The Empatica Embrace Watch And Smartphone-Based Alert System | NCT03207685 | Empatica, Inc. | user2@example.com | None | 2017-06-30 | 2022-01-31 | 2023-01-31 | - | - | 2025-07-14 |